LIV Institute Seminar List
joint lecture club: Virus-associated hematologic malignancies
Wednesday, 07. December 2016 - 13:30Nilgün Tekin-Bubenheim (Viral Transformation)
phd seminar: Metabolic stress and immune activation: Consequences of HIV-1 infection, exposure to HIV-1 and antiretroviral therapy // Characterization of human pathogen containing aerosols and modeling of their air transport // Native mass spectrometry
Wednesday, 30. November 2016 - 10:00Caroline Pfeifer (Altfeld lab)
Elisabeth Pfrommer (Gabriel lab)
Hao Yan (Uetrecht lab)
Joint lecture club: Managing chronic viral infections - progress and challenge
Wednesday, 23. November 2016 - 13:30Wilhelm Salzberger (Viral Immunology)
phd seminar: Role of the proteins m139, m140 and m141 during MCMV infection // Mechanisms underlying sex differences in innate and adaptive immunity to viral infections
Wednesday, 16. November 2016 - 13:30Olha Puhach (Brune lab)
Sven Hagen (Altfeld lab)
cancelled: joint lecture club: 26 Years of gene therapy - an overview
Wednesday, 09. November 2016 - 13:30Helga Hofmann-Sieber (Viral Transformation)
phd seminar: Searching for Inhibitors of the viral alkaline nuclease UL98
Wednesday, 02. November 2016 - 13:30Theodore Potgieter (Brune lab)
joint lecture club: Virus-induced obesity - fact or coincidence?
Wednesday, 26. October 2016 - 13:30Carolin Bürck (Viral Transformation)
phd seminar: The SUMO-modification of cellular and viral proteins and its effect during the early adenoviral infection and transformation // Proteomic and Microscopic Analysis of Lipid Droplets and Associated Proteins in Hepatitis C Virus- infected Cells
Tuesday, 18. October 2016 - 13:30Steewen Speck (Dobner lab)
Kathrin Rösch (Herker lab)
postponed to january 2017: Joint lecture club: Cutting edge antiviral therapies with designer nucleases and recombinases
Wednesday, 12. October 2016 - 13:30Niklas Beschorner (Antiviral Strategies)
joint lecture club: HIV latent reservoirs - novel approaches to wake a sleeping provirus
Wednesday, 05. October 2016 - 13:30Ulrike Lange (Antiviral Strategies)